Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Efficacy of first-line treatments in the elderly and non-elderly patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: a network meta-analysis

Fig. 3

Network diagrams of comparisons on different outcomes of treatments in different race groups of patients with non-small cell lung cancer (NSCLC). A) Comparisons for progression free survival on patients below 65 years old. B) Comparisons for overall survival on patients below 65 years old. C) Comparisons for progression free survival on patients over 65 years old. D) Comparisons for overall survival on patients over 65 years old

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us